BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 17075819)

  • 1. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
    Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
    Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein.
    Espada G; Maldonado Cocco JA; Fertig N; Oddis CV
    J Rheumatol; 2009 Nov; 36(11):2547-51. PubMed ID: 19833756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
    Gunawardena H; Wedderburn LR; North J; Betteridge Z; Dunphy J; Chinoy H; Davidson JE; Cooper RG; McHugh NJ;
    Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.
    Sato S; Hirakata M; Kuwana M; Suwa A; Inada S; Mimori T; Nishikawa T; Oddis CV; Ikeda Y
    Arthritis Rheum; 2005 May; 52(5):1571-6. PubMed ID: 15880816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
    Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
    J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
    Gunawardena H; Wedderburn LR; Chinoy H; Betteridge ZE; North J; Ollier WE; Cooper RG; Oddis CV; Ramanan AV; Davidson JE; McHugh NJ;
    Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis.
    Betteridge Z; Gunawardena H; North J; Slinn J; McHugh N
    Arthritis Rheum; 2007 Sep; 56(9):3132-7. PubMed ID: 17763420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
    Muro Y; Ishikawa A; Sugiura K; Akiyama M
    Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays.
    Labrador-Horrillo M; Martínez MA; Selva-O'Callaghan A; Trallero-Araguás E; Balada E; Vilardell-Tarrés M; Juarez C
    Ann Rheum Dis; 2012 Jun; 71(6):993-6. PubMed ID: 22294626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
    Kang EH; Nakashima R; Mimori T; Kim J; Lee YJ; Lee EB; Song YW
    BMC Musculoskelet Disord; 2010 Sep; 11():223. PubMed ID: 20875136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myositis-specific autoantibodies and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
    Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
    Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.
    Chinoy H; Salway F; John S; Fertig N; Tait BD; Oddis CV; Ollier WE; Cooper RG;
    Rheumatology (Oxford); 2007 Sep; 46(9):1411-6. PubMed ID: 17586554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.
    Shamim EA; Rider LG; Pandey JP; O'Hanlon TP; Jara LJ; Samayoa EA; Burgos-Vargas R; Vazquez-Mellado J; Alcocer-Varela J; Salazar-Paramo M; Kutzbach AG; Malley JD; Targoff IN; Garcia-De la Torre I; Miller FW
    Arthritis Rheum; 2002 Jul; 46(7):1885-93. PubMed ID: 12124873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.
    Kaji K; Fujimoto M; Hasegawa M; Kondo M; Saito Y; Komura K; Matsushita T; Orito H; Hamaguchi Y; Yanaba K; Itoh M; Asano Y; Seishima M; Ogawa F; Sato S; Takehara K
    Rheumatology (Oxford); 2007 Jan; 46(1):25-8. PubMed ID: 16728436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
    Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
    Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune manifestations of inflammatory muscle disease.
    Targoff IN
    Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study.
    Fujikawa K; Kawakami A; Kaji K; Fujimoto M; Kawashiri S; Iwamoto N; Aramaki T; Ichinose K; Tamai M; Kamachi M; Nakamura H; Ida H; Origuchi T; Ishimoto H; Mukae H; Kuwana M; Kohno S; Takehara K; Sato S; Eguchi K
    Scand J Rheumatol; 2009; 38(4):263-7. PubMed ID: 19444719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy.
    Furuya T; Hakoda M; Tsuchiya N; Kotake S; Ichikawa N; Nanke Y; Nakajima A; Takeuchi M; Nishinarita M; Kondo H; Kawasaki A; Kobayashi S; Mimori T; Tokunaga K; Kamatani N
    J Rheumatol; 2004 Sep; 31(9):1768-74. PubMed ID: 15338498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.